In this population of newly diagnosed patients with CML, over the course of treatment newly emerging BCR::ABL1 mutations were identified in 1 patient only (asciminib arm), which were detected in or near the myristoyl pocket (A337T/L340Q) at week 41. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.